Advanced Solid Tumours
Advanced solid tumours are cancers that have spread from their original site to other parts of the body, often leading to more severe symptoms and requiring more intensive treatment.
Advanced Cancer: BI 1703880 with Ezabenlimab
We are testing how well different doses of BI 1703880 work with ezabenlimab in people with advanced solid tumors. This study aims to see how well these treatments are tolerated.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Vall D Hebron Institute Of Oncology
Oncology Department
Alboraya, Spain
Hospital Universitario Hm Sanchinarro
START Madrid-HM CIOCC Early Phase Program
Chamartín, Spain
Fundacion Instituto Valenciano De Oncologia
Servicio de Oncología
Valencia, Spain
Sponsor: Boehringer Ingelheim International GmbH
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.